FBP1, a putative tumor suppressor, has been shown previously to inhibit tumor progression by inhibiting aerobic glycolysis and reducing the Warburg effect 30 and/or antagonizing the function of HIF in renal cancer 31. This evidence concerns the gene FBP1 and renal carcinoma.